Compound Detail

CHEMBL3683777

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

COc1ccc(S(=O)(=O)N(CC(C)C)C[C@@H](O)[C@H](Cc2ccccc2)NC(=O)c2cccc(C(=O)N3CCC[C@H]3c3nc(C)cs3)c2)cc1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL3683777
Phase	Preclinical
Structure Type	MOL
InChI Key	ZHCCHBWXFODCGA-DHWXLLNHSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

704.9

MW (Da)

5.49

ALogP

HBA

HBD

129.1

PSA (Å²)

0.18

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

Ki 2 meas. best 7.52

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
Protease CHEMBL2366517	Ki	7.52	7.52	30.0	1
Unchecked CHEMBL612545	Ki	7.51	7.51	30.8	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
Protease	Ki	=	30.0	nM	7.52	Inhibition Assay: Without being bound by theory, it is suggested that the compou...	-
Unchecked	Ki	=	30.8	nM	7.51	Inhibition of HIV1 protease using fluorogenic substrate by continuous fluorometr...	28434781

PubMed	DOI	Target Context	# Activities
28434781	10.1016/j.bmc.2017.04.005	Human immunodeficiency virus 1	1
28434781	10.1016/j.bmc.2017.04.005	Unchecked	1

Data from ChEMBL 36 via Core Engine